Skip to main content

Articles

Page 70 of 70

  1. Biochemical and histochemical studies have both previously indicated plasma membrane-associated carbonic anhydrase (CA) activity in hepatocytes which has been assumed to be CA IV. However, immunohistochemical ...

    Authors: Seppo Parkkila, Antti J Kivelä, Kari Kaunisto, Anna-Kaisa Parkkila, Jukka Hakkola, Hannu Rajaniemi, Abdul Waheed and William S Sly
    Citation: BMC Gastroenterology 2002 2:13
  2. To evaluate changes in H pylori infection prevalence in Greece during a ten-year period, and to examine its antigenic profile.

    Authors: Periklis Apostolopoulos, Irene Vafiadis-Zouboulis, Michael Tzivras, Dimitrios Kourtessas, Nicolaos Katsilambros and Athanasios Archimandritis
    Citation: BMC Gastroenterology 2002 2:11
  3. Intestinal tuberculosis is a rare disease in western countries, affecting mainly immigrants and immunocompromised patients. Intestinal tuberculosis is a diagnostic challenge, especially when active pulmonary i...

    Authors: Constantinos Chatzicostas, Ioannis E Koutroubakis, Maria Tzardi, Maria Roussomoustakaki, Panagiotis Prassopoulos and Elias A Kouroumalis
    Citation: BMC Gastroenterology 2002 2:10
  4. Endothelial MAdCAM-1 (mucosal addressin cell adhesion molecule-1) expression is associated with the oxidant-dependent induction and progress of inflammatory bowel disease (IBD). Melatonin, a relatively safe, p...

    Authors: Makoto Sasaki, Paul Jordan, Takashi Joh, Makotoh Itoh, Michael Jenkins, Kevin Pavlick, Alireza Minagar and Steven J Alexander
    Citation: BMC Gastroenterology 2002 2:9
  5. It has been suggested that one aspect of non-steroidal anti-inflammatory drugs induced intestinal damage is due to either uncoupling of mitochondrial oxidative phosphorylation or inhibition of electron transpo...

    Authors: S Somasundaram, R Simpson, S Rafi, JK Shergill, I Bjarnason and J Wrigglesworth
    Citation: BMC Gastroenterology 2002 2:8
  6. Helicobacter pylori (H. pylori) has been etiologically linked with primary gastric lymphoma (PGL) and gastric carcinoma (GC). There are a few reports of occurrence of both diseases in the same patient with H. py...

    Authors: Uday C Ghoshal, Debashish Guha, Santu Bandyopadhyay, Chiranjib Pal, Srikanta Chakraborty, Ujjala Ghoshal, Tamal K Ghosh, Bhaskar B Pal and Prabir K Banerjee
    Citation: BMC Gastroenterology 2002 2:6
  7. An increased prevalence of coeliac disease in patients with primary biliary cirrhosis has been recently reported. However, in other studies the association has not been confirmed. There have been no formal att...

    Authors: Costantinos Chatzicostas, Maria Roussomoustakaki, Dimitrios Drygiannakis, Maria Niniraki, Maria Tzardi, Mary Koulentaki, Philippos Dimoulios, Ioannis Mouzas and Elias Kouroumalis
    Citation: BMC Gastroenterology 2002 2:5
  8. Absorption of water and Na+ in descending colonic crypts is dependent on the barrier function of the surrounding myofibroblastic pericryptal sheath. Here the effects of high and low Na+ diets and exposure to whol...

    Authors: Jay R Thiagarajah, Nina M Griffiths, Kevin C Pedley and Richard J Naftalin
    Citation: BMC Gastroenterology 2002 2:4
  9. Cholelithiasis is the gallstone disease (GSD) where stones are formed in the gallbladder. The main function of the gallbladder is to concentrate bile by the absorption of water and sodium. GSD has high prevale...

    Authors: Oleg Kleiner, Jagannathan Ramesh, Mahmoud Huleihel, Beny Cohen, Keren Kantarovich, Chen Levi, Boris Polyak, Robert S Marks, Jacov Mordehai, Zahavi Cohen and Shaul Mordechai
    Citation: BMC Gastroenterology 2002 2:3
  10. Alcoholic hepatitis is characterized by acute, or acute-on-chronic hepatic failure and associated with a high mortality. Specific therapies should be considered for those at high risk of mortality. The Mayo En...

    Authors: Milan Sheth, Mark Riggs and Tushar Patel
    Citation: BMC Gastroenterology 2002 2:2
  11. Health Related Quality of Life (HRQoL) is an important outcome measure in Inflammatory Bowel Disease (IBD). The aim of our study was to assess HRQoL in a population of 135 Greek patients with IBD.

    Authors: Athanasios G Pallis, Ioannis G Vlachonikolis and Ioannis A Mouzas
    Citation: BMC Gastroenterology 2002 2:1
  12. High dose interferon induction treatment of hepatitis C viral infection blocks viral production over 95%. Since dose reduction is often performed due to clinical considerations, the effect of dose reduction on...

    Authors: Frank C Bekkering, Avidan U Neumann, Johannes T Brouwer, Rachel S Levi-Drummer and Solko W Schalm
    Citation: BMC Gastroenterology 2001 1:14
  13. Since the introduction of molecular diagnostic tools such as markers for hepatitis C and different autoimmune diseases, liver biopsy is thought to be useful mainly for staging but not for diagnostic purposes. ...

    Authors: Claudia Spycher, Arthur Zimmermann and Juerg Reichen
    Citation: BMC Gastroenterology 2001 1:12
  14. The only US guidelines listed in the National Guideline Warehouse for the diagnosis of Irritable Bowel Syndrome (IBS) are the expert opinion guidelines published by The American Gastroenterology Association. A...

    Authors: Barbara P Yawn, Eva Lydick, G Richard Locke, Peter C Wollan, Susan L Bertram and Margary J Kurland
    Citation: BMC Gastroenterology 2001 1:11
  15. Excessive loss of bile acids in stool has been reported in patients with cystic fibrosis. Some data suggest that a defect in mucosal bile acid transport may be the mechanism of bile acid malabsorption in these...

    Authors: Matthias Stelzner, Sivagurunathan Somasundaram, Sum P Lee and Rahul Kuver
    Citation: BMC Gastroenterology 2001 1:10
  16. Pancreatic cancer is a biologically aggressive disease with less than 20% of patients suitable for a "curative" surgical resection. This, combined with the poor 5-year survival indicates that effective palliat...

    Authors: Beverley G Fosh, Jonathon Guy Finch, Adrian A Anthony, Michael Texler and Guy J Maddern
    Citation: BMC Gastroenterology 2001 1:9
  17. Sulfasalazine is a widely used anti-inflammatory agent in the treatment of inflammatory bowel disease and several rheumatological disorders. Although as many as 20% of treated patients may experience reversibl...

    Authors: Leonard G Quallich, Joel Greenson, Hilary M Haftel and Robert J Fontana
    Citation: BMC Gastroenterology 2001 1:8
  18. Physicians' perspectives regarding hepatitis C shape their approach to patient management. We used utility analysis to evaluate physicians' perceptions of hepatitis C-related health states (HS) and their thres...

    Authors: Raj Patil, Scott J Cotler, Geraldine Banaad-Omiotek, Robert A McNutt, Michael D Brown, Sheldon Cotler and Donald M Jensen
    Citation: BMC Gastroenterology 2001 1:6
  19. MAdCAM-1 is an adhesion molecule expressed in Peyer's patches and lymphoid tissues which is mobilized by cytokines like TNF-α and is a major determinant of lymphocyte trafficking to the gut in human inflammato...

    Authors: Tadayuki Oshima, Paul Jordan, Matthew B Grisham, Jonathan S Alexander, Merilyn Jennings, Makotoh Sasaki and Kenneth Manas
    Citation: BMC Gastroenterology 2001 1:5
  20. Hepatitis C is a serious problem on the Greek island of Crete, where a high prevalence of antibodies against hepatitis C (anti-HCV) has recently been reported. This article reports the findings of a study carr...

    Authors: Dimitrios Drygiannakis, Christos Lionis, Ioannis Drygiannakis, Georgios Pappas and Elias Kouroumalis
    Citation: BMC Gastroenterology 2001 1:4
  21. Oral anticoagulants like the coumarin derivatives are characterised by a particularly narrow therapeutic range. Any interfering co-medication can pose a challenge to establishing a stable anticoagulant dosage ...

    Authors: Christa Enderle, Willi Müller and Ulrich Grass
    Citation: BMC Gastroenterology 2001 1:2
  22. Jejunogastric intussusception (JGI) is a rare but potentially very serious complication of gastrectomy or gastrojejunostomy. To avoid mortality early diagnosis and prompt surgical intervention is mandatory.

    Authors: Athanasios J Archimandritis, Nikos Hatzopoulos, Petros Hatzinikolaou, Stavros Sougioultzis, Dimitris Kourtesas, George Papastratis and Michalis Tzivras
    Citation: BMC Gastroenterology 2001 1:1

Annual Journal Metrics

  • Citation Impact
    2.855 - 2-year Impact Factor (2021)
    3.230 - 5-year Impact Factor (2021)
    1.039 - SNIP (Source-Normalized Impact per Paper)
    0.737 - SJR (SCImago Journal Rank)

    Speed
    51 days to first decision for all manuscripts (Median)
    157 days to first decision for reviewed manuscripts only (Median)

    Usage 
    2,299,334 Downloads (2021)
    5,001 Altmetric mentions (2021)

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Trending Articles

Click here to view which Articles have been shared the most this year!